돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 449627생성일: 2026년 10월 25일

Potassium Phosphate, Tribasic → 2-(6-tert-butyl-8-fluoro-1-oxophthalazin-2(1H)-yl)-6-(5-(1,5-dimethyl-1H-pyrazol-3-ylamino)-1-methyl-6-oxo-1,6-dihydropyridazin-3-yl)benzyl acetate

https://huagongshe.com/reaction/449627

반응식

참여 물질

역할이름HCID투입량
반응물Potassium Phosphate, TribasicHCID 62657—
반응물2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 11155794—
반응물6-chloro-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-2-methylpyridazin-3(2H)-oneHCID 58540002—
반응물potassium (2-(acetoxymethyl)-3-(6-tert-butyl-8-fluoro-1-oxophthalazin-2(1H)-yl)phenyl)trifluoroborateHCID 87134390—
촉매(1E,4E)-1,5-diphenylpenta-1,4-dien-3-one; palladiumHCID 6505921—
용매1-ButanolHCID 263—
용매WaterHCID 962—
생성물2-(6-tert-butyl-8-fluoro-1-oxophthalazin-2(1H)-yl)-6-(5-(1,5-dimethyl-1H-pyrazol-3-ylamino)-1-methyl-6-oxo-1,6-dihydropyridazin-3-yl)benzyl acetateHCID 6674315681%

반응 조건

온도100 °C

반응 단계

In a 50 mL test tube, 6-chloro-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-2-methylpyridazin-3(2H)-one (100 mg, 394 μmol, Eq: 1.00) and potassium (2-(acetoxymethyl)-3-(6-tert-butyl-8-fluoro-1-oxophthalazin-2(1H)-yl)phenyl)trifluoroborate (224 mg, 473 μmol, Eq: 1.2) were combined with BuOH (4.00 ml) to give a orange solution. Water (1.00 ml) was added. X-PHOS (18.8 mg, 39.4 μmol, Eq: 0.1) and potassium phosphate tribasic (167 mg, 788 μmol, Eq: 2) were added. Bis(dibenzylideneacetone)palladium (11.3 mg, 19.7 μmol, Eq: 0.05) was added. The reaction mixture was purged with argon. The solution warmed in a oil bath at 100° C. for 1.5 hours. The solution was allowed to cool to room temperature. The reaction mixture was poured into 75 mL H2O and extracted with DCM. The organic layer was concentrated in vacuo. The crude material was purified by flash chromatography (silica gel, 25 g, 0% to 30% (60:10:1 DCM:MeOH:NH4OH)/DCM gradient) to give a solid. The solid was triturated with Et2O to give 2-(6-tert-butyl-8-fluoro-1-oxophthalazin-2(1H)-yl)-6-(5-(1,5-dimethyl-1H-pyrazol-3-ylamino)-1-methyl-6-oxo-1,6-dihydropyridazin-3-yl)benzyl acetate (186 mg, 81%). LC/MS-ESI observed [M+H]+ 586.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08481540B2
출처 데이터셋uspto-grants-2013_07
ORD IDord-a654cc3c6c654e2eb1efd25312f16a40
출처 메모uspto-grants-2013_07